Ibrance and Kisquali both raise the risk of neutropenia, but Kisquali also comes with heart rhythm risk and liver toxicity, while severe diarrhoea has been seen in patients taking Verzenio.

A brilliant idea for helping cancer patients is just that – an idea – until it is put into practice. But turning research into something that can improve patient outcomes and benefit healthcare ...